Logo Medical Science Monitor Basic Research

Call: 1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research

03 November 1997

Parameters of bone metabolism in dialysed children

Helena Zi—ółkowska, Małgorzata Pańczyk-Tomaszewska, Maria Sieniawska

Med Sci Monit 1997; 3(6): CR895-903 :: ID: 501828

Abstract

The aim of the study was an assessment of the disorders in calcium and phosphorus balance in children participating in the program of repeated haemodialyses (HD) as well as a continuous ambulatory peritoneal dialysis (CAPD). 29 patients - aged 3 to 20 (mean age 11) - were included in the study; 18 of them received HD and 11 were treated with CAPD. All patients were given alphacalcidol at the dose of 0.005 to 0.023 µg/kg/24 hours and CaCO3 at the dose of 50-200 mg/kg/24 hours. The patients from both groups (HD and CAPD) did not differ from each other with respect to their age, the time of dialysis and the dose of CaCO3. The dose of alphacalcidol was significantly higher in the group treated with CAPD. Every 4 months, patientsÕ serum was examined to determine the concentration of the following: Ca, P, parathormone (PTH int), alkaline phosphatase (AP), osteocalcin (OC) and procollagen IC (PICP). In the group of peritoneally dialysed children we found lower concentrations of phosphorus and PTH int, and higher AP activity. Low concentrations of PTH were found in 60% of patients from both groups, which in 54% of cases were accompanied by low bone metabolism markers. The number of hypercalcaemia episodes equalled 17% in HD patients and 15% in the group with CAPD. The concentrations P>3.5 mEq/l were found in 40% of tests in HD group and in 17.7% of tests in CAPD patients. Hypercalcaemia episodes did not last long and they did not cause clinical problems. Increased P concentrations resulted either from inappropriate diet or not taking CaCO3 at the time of meals. The application of alphacalcidol and CaCO3 effectively prevents the development of hyperparathyroidism in the course of chronic renal failure, although the simultaneous use of high calcium concentration may result in the development of osteopathy with decreased bone turnover. A systematic determination of the concentration of Ca, P, PTH int and a selected bone metabolism marker is necessary for the evaluation of bone metabolism in children undergoing dialysis.

Keywords: renal osteodystrophy, Calcium Carbonate, alphacalcidol, bone metabolism markers

Comments

Most Viewed Current Articles

13 Apr 2020 : Original article  

Outcome of 24 Weeks of Combined Schroth and Pilates Exercises on Cobb Angle, Angle of Trunk Rotation, Chest...

DOI :10.12659/MSMBR.920449

Med Sci Monit Basic Res 2020; 26:e920449

11 May 2020 : Original article  

Analysis of Psychological and Sleep Status and Exercise Rehabilitation of Front-Line Clinical Staff in the ...

DOI :10.12659/MSMBR.924085

Med Sci Monit Basic Res 2020; 26:e924085

05 Jan 2021 : Review article  

A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against...

DOI :10.12659/MSMBR.929207

Med Sci Monit Basic Res 2021; 27:e929207

10 Aug 2020 : Clinical Research  

Effects of Cognitive Task Training on Dynamic Balance and Gait of Patients with Stroke: A Preliminary Rando...

DOI :10.12659/MSMBR.925264

Med Sci Monit Basic Res 2020; 26:e925264

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor Basic Research eISSN: 2325-4416
Medical Science Monitor Basic Research eISSN: 2325-4416